Belbuca Prescribing & Dosing Schedule

Dosage & Administration Drug label Financial assistance Patient education People also ask

Belbuca(buprenorphine)

Belbuca 75 MCG Buccal Film

Dosage & Administration

* BELBUCA should be prescribed only by healthcare professionals who are knowledgeable about the use of extended-release/long-acting opioids and how to mitigate the associated risks.
* Use the lowest effective dosage for the shortest duration of time consistent with individual patient treatment goals. Reserve titration to higher doses of BELBUCA for patients in whom lower doses are insufficiently effective and in whom the expected benefits of using a higher dose opioid clearly outweigh the substantial risks
* Initiate the dosing regimen for each patient individually, taking into account the patient's underlying cause and severity of pain, prior analgesic treatment and response, and risk factors for addiction, abuse, and misuse.
* Respiratory depression can occur at any time during opioid therapy, especially when initiating and following dosage increases with BELBUCA. Consider this risk when selecting an initial dose and when making dose adjustments. .
* Discuss availability of naloxone with the patient and caregiver and assess each patient's need for access to naloxone, both when initiating and renewing treatment with BELBUCA. Consider prescribing naloxone based on the patient's risk factors for overdose.
* For opioid-naïve patients: Initiate therapy with 75 mcg BELBUCA once daily or every 12 hours, as tolerated, for at least 4 days before increasing dose to 150 mcg every 12 hours.
* Conversion from other opioids to BELBUCA: Taper current daily opioid dose to 30 mg oral morphine sulfate equivalents (MSE) or less prior to initiating therapy with BELBUCA.
* For patients taking less than 30 mg oral MSE, initiate therapy with 75 mcg once daily or every 12 hours.
* For patients taking between 30 mg and 89 mg oral MSE, initiate therapy with 150 mcg BELBUCA every 12 hours following analgesic taper.
* For patients taking between 90 mg and 160 mg oral MSE, initiate therapy with 300 mcg BELBUCA every 12 hours following analgesic taper.
* For patients taking greater than 160 mg oral MSE, consider alternate analgesic.

* BELBUCA doses of 600 mcg, 750 mcg, and 900 mcg are only for use following titration from lower doses of BELBUCA.
* Patients with Severe Hepatic Impairment: Reduce the starting and incremental dose by half that of patients with normal liver function.
* Patients with Oral Mucositis: Reduce the starting and incremental dose by half that of patients without mucositis.
* Do not abruptly discontinue BELBUCA in a physically-dependent patient because rapid discontinuation of opioid analgesics has resulted in serious withdrawal symptoms, uncontrolled pain, and suicide.

drug label

Belbuca Prescribing Information

Report Adverse Event

financial assistance

Belbuca Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Belbuca Patient Education

Getting started on Belbuca

Instructions For Use: Pain Management

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Belbuca

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Belbuca FAQs

How is the dosage of Belbuca?Belbuca is available in 7 dosages, including 0.075 mg Film, 0.15 mg Film, 0.3 mg Film, 0.45 mg Film, 0.6 mg Film, 0.75 mg Film and 0.9 mg Film

What does Belbuca treat?Belbuca treats Heroin Dependence and Pain

What is Belbuca made of?Belbuca contains buprenorphine which is a Partial Opioid Agonist

How Is Belbuca Administered?Belbuca is administered as a Buccal

What Are The Belbuca Mechanism Of Action?Belbuca mechanism of action is Partial Opioid Agonists

FAQ Data Source

Dosage & Administration

Dosage & Administration

drug label

Belbuca Prescribing Information

financial assistance

Belbuca Financial Assistance Options

Copay savings program

patient education

Belbuca Patient Education

Getting started on Belbuca

Patient toolkit

people also ask

Belbuca FAQs